EGFR and nasopharyngeal carcinoma: Similar to our results, the efficacy of Zn-BC-AM-PDT was increased in nasopharyngeal carcinoma cells (NPC) through the inhibition of EGFR/PI3K/Akt and EGFR/MEK/ERK signaling pathways using an EGFR inhibitor AG1478 [41].